Photodynamic and antiangiogenic activities of parietin liposomes in triple negative breast cancer.


Journal

Biomaterials advances
ISSN: 2772-9508
Titre abrégé: Biomater Adv
Pays: Netherlands
ID NLM: 9918383886206676

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 21 07 2021
revised: 25 10 2021
accepted: 06 11 2021
pubmed: 7 5 2022
medline: 9 8 2022
entrez: 6 5 2022
Statut: ppublish

Résumé

Parietin (PTN) is an anthraquinone with promising efficacy in the inhibition of cancer cell proliferation and tumor growth. Due to its hydrophobicity, PTN is sparingly soluble under physiological conditions and has a low bioavailability. Hence, we presented PTN in liposomes to overcome these drawbacks. The prepared liposomes were characterized and their stability was also assessed in serum. Singlet oxygen quantum yield of PTN loaded liposomes was indirectly quantified using uric acid. The intracellular uptake of liposomes was studied by CLSM which indicated the perinuclear localization of PTN liposomes. Cellular viability assay and live/dead staining demonstrated both light and dose-dependent phototoxicity of PTN on the human breast cancer cell line. The mechanism of cellular uptake was investigated using different pathway inhibitors and the results showed that clathrin-mediated endocytosis is predominant. The colocalization experiment indicated that PTN is localized in both mitochondria and lysosomes. These findings together with flow cytometry analysis elucidated that apoptosis is the main mechanism underlying cell death post-PDT. Finally, the antiangiogenic effect of PTN liposomes was further evaluated in the chorioallantoic membrane (CAM) model and the results indicated that PDT induced vascular response was confined to the irradiated area leaving the non-irradiated unscathed.

Identifiants

pubmed: 35523642
pii: S0928-4931(21)00683-4
doi: 10.1016/j.msec.2021.112543
pii:
doi:

Substances chimiques

Angiogenesis Inhibitors 0
Liposomes 0
Photosensitizing Agents 0
physcione H6PT94IV61
Emodin KA46RNI6HN

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112543

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Abdallah M Ayoub (AM)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.

Muhammed U Amin (MU)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany; Department of Pharmacy, The University of Lahore, Lahore, Pakistan.

Ghazala Ambreen (G)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany.

Alice Abu Dayyih (AA)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany.

Ahmed M Abdelsalam (AM)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Asiut, Egypt.

Ahmed Somaida (A)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany.

Konrad Engelhardt (K)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany.

Matthias Wojcik (M)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany.

Jens Schäfer (J)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany.

Udo Bakowsky (U)

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Germany. Electronic address: ubakowsky@aol.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH